Manning & Napier Group's CVS Position Overview
Manning & Napier Group (via Manning & Napier Advisors LLC) currently holds 94,235 shares of CVS Health Corporation (CVS) worth $9.76 M, representing 0.13% of the portfolio. First purchased in 2014-Q2, this long-term strategic position has been held for 47 quarters.
Based on 13F filings since 2013, Manning & Napier Group has maintained a long-term strategic position in CVS, representing a significant commitment to this investment thesis. Largest addition occurred in Q2 2023, adding 272,721 shares. Largest reduction occurred in Q1 2020, reducing 367,553 shares.
Analysis based on 13F filings available since 2013 Q2
Manning & Napier Group's CVS Health Corporation (CVS) Holding Value Over Time
Track share changes against reported price movement
Quarterly CVS Health Corporation (CVS) Trades by Manning & Napier Group
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +94,225 | Add 942250.00% | 94,235 | $103.58 |
| Q1 2026 | -73 | Reduce 87.95% | 10 | $70.10 |
| Q4 2025 | -42,935 | Reduce 99.81% | 83 | $79.86 |
| Q3 2025 | -57,032 | Reduce 57.00% | 43,018 | $75.39 |
| Q2 2025 | +10,050 | Add 11.17% | 100,050 | $68.98 |
| Q1 2025 | +90,000 | New Buy | 90,000 | $67.75 |
| Q2 2024 | -209,719 | Sold Out | 0 | $0.00 |
| Q1 2024 | -277,263 | Reduce 56.93% | 209,719 | $79.75 |
| Q4 2023 | -38,258 | Reduce 7.28% | 486,982 | $78.96 |
| Q3 2023 | +25,779 | Add 5.16% | 525,240 | $69.82 |
| Q2 2023 | +272,721 | Add 120.28% | 499,461 | $69.13 |
| Q1 2023 | +814 | Add 0.36% | 226,740 | $74.31 |
| Q4 2022 | -3,144 | Reduce 1.37% | 225,926 | $93.19 |
| Q3 2022 | -10,498 | Reduce 4.38% | 229,070 | $95.36 |
| Q2 2022 | +239,568 | New Buy | 239,568 | $92.65 |
| Q2 2020 | -34,067 | Sold Out | 34,067 | $59.32 |
| Q1 2020 | -367,553 | Reduce 91.52% | 34,067 | $59.32 |
| Q4 2019 | +34,792 | Add 9.48% | 401,620 | $74.29 |
| Q3 2019 | +2,940 | Add 0.81% | 366,828 | $63.06 |
| Q2 2019 | +63,925 | Add 21.31% | 363,888 | $54.49 |
| Q1 2019 | +67,558 | Add 29.07% | 299,963 | $53.93 |
| Q4 2018 | +20,134 | Add 9.49% | 232,405 | $65.52 |
| Q3 2018 | +16,031 | Add 8.17% | 212,271 | $78.72 |
| Q2 2018 | +4,199 | Add 2.19% | 196,240 | $64.34 |
| Q1 2018 | +46,659 | Add 32.09% | 192,041 | $62.21 |
| Q4 2017 | +145,383 | Add 0.00% | 145,382 | $72.50 |
| Q3 2017 | -139,815 | Reduce 47.15% | 156,712 | $81.31 |
| Q2 2017 | +154,847 | Add 109.29% | 296,527 | $80.45 |
| Q1 2017 | -48,430 | Reduce 25.47% | 141,680 | $78.49 |
| Q4 2016 | +103,100 | Add 118.49% | 190,110 | $78.91 |
| Q3 2016 | +480 | Add 0.55% | 87,010 | $88.99 |
| Q2 2016 | -560 | Reduce 0.64% | 86,530 | $95.74 |
| Q1 2016 | +790 | Add 0.92% | 87,090 | $103.72 |
| Q4 2015 | +400 | Add 0.47% | 86,300 | $97.76 |
| Q3 2015 | -2,330 | Reduce 2.64% | 85,900 | $96.47 |
| Q2 2015 | -52,770 | Reduce 37.43% | 88,230 | $104.87 |
| Q1 2015 | +15,804 | Add 12.62% | 141,000 | $103.21 |
| Q4 2014 | +4,426 | Add 3.66% | 125,196 | $96.30 |
| Q3 2014 | -12,380 | Reduce 9.30% | 120,770 | $79.59 |
| Q2 2014 | +133,150 | New Buy | 133,150 | $75.37 |
Manning & Napier Group's CVS Health Corporation Investment FAQs
Manning & Napier Group first purchased CVS Health Corporation (CVS) in Q2 2014, acquiring 133,150 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Manning & Napier Group has held CVS Health Corporation (CVS) for 47 quarters since Q2 2014.
Manning & Napier Group's largest addition to CVS Health Corporation (CVS) was in Q2 2023, adding 499,461 shares worth $34.53 M.
According to the latest 13F filing for Q2 2026, Manning & Napier Group's firm, Manning & Napier Advisors LLC, owns 94,235 shares of CVS Health Corporation (CVS), valued at approximately $9.76 M.
As of the Q2 2026 filing, CVS Health Corporation (CVS) represents approximately 0.13% of Manning & Napier Group's publicly disclosed stock portfolio, making it one of their key holdings.
Manning & Napier Group's peak holding in CVS Health Corporation (CVS) was 525,240 shares, as reported at the end of Q3 2023.